|
|
Science Sparks @ ACTREC
|
7 March 2022 |
Vol. No. 11; Issue No. 516 |
|
Publications
|
1. Khanna N, Kumar A, Sehra N, Ghosh -Laskar S, Mummudi N, Gupta T, Tibdewal A, Pathak R, Wadasadawala T, Krishnatry R, Chopra S, Goda J, Chatterjee A, Budrukkar A, Gurram L, Engineer R, Murthy V, Swain M, Laskar S, Sarin R, Agarwal J (2022). Compliance of radiotherapy treatment at a tertiary cancer center in India—A clinical audit. Indian Journal of Medical and Paediatric Oncology. 43(1): 84-91.
2. Anand K, Mishra G, Pimple S, Biswas S, Kulkarni V, Salunkhe G (2022). Cross-sectional study of HPV self-sampling among Indian women— A way forward. Indian Journal of Medical and Paediatric Oncology. 43(1): 103-108.
3. Kulkarni R, Gupta S, Maheshwari A (2022). Gynecologic Oncology: On the Shoulders of Giants. Indian Journal of Medical and Paediatric Oncology. 43(1): 34-39.
4. Singh A, Nair N, Gupta S, Parmar V, Prabhu A, Hawaldar R, Badwe R (2022). Effect of menopausal status on chemotherapy-induced peripheral neuropathy: Single-institution retrospective audit. Indian Journal of Medical and Paediatric Oncology. 43(1): 68-72.
5. Ostwal V, Ramaswamy A, Gota V, Bhargava P, Srinivas S, Shriyan B, Jadhav S, Goel M, Patkar S, Mandavkar S, Naughane D, Daddi A, Nashikkar C, Shetty N, Ankathi S, Banavali S (2022). Phase I Study Evaluating Dose De-escalation of Sorafenib with Metformin and Atorvastatin in Hepatocellular Carcinoma (SMASH). The Oncologist
|
|
|
Interesting Reads
|
Ma T, Tian X, Zhang B, Li M, Wang Y, Yang C, Wu J, Wei X, Qu Q, Yu Y, Long S, Feng JW, Li C, Zhang C, Xie C, Wu Y, Xu Z, Chen J, Yu Y, Huang X, He Y, Yao L, Zhang L, Zhu M, Wang W, Wang ZC, Zhang M, Bao Y, Jia W, Lin SY, Ye Z, Piao HL, Deng X, Zhang CS, Lin SC. Low-dose metformin targets the lysosomal AMPK pathway through PEN2. Nature. 603(7899):159-165, 2022.
|
|
Legends of Science
|
|
Jaya Sivaswami Tyagi
Jaya Tyagi obtained her doctorate from the University of Delhi in 1979. During her association with AIIMS, New Delhi, she contributed to the research areas of Molecular Biology, Mycobacteriology, and Gene Regulation. Her specialization was molecular pathogenesis regarding dormancy adaptation of Mycobacterium tuberculosis. She has developed novel technologies for diagnosing TB and drug resistance relevant to India’s national strategic plan for TB elimination. She is a Fellow of the National Academy of Sciences, Indian Academy of Sciences, Indian National Science Academy. Dr. Tyagi received many prestigious awards - P.S.Sarma Memorial Award; Dr. Kona Sampath Kumar Memorial Prize; New Millenium Science Medal of Indian Science Congress; National Women Bioscientist Award.
|
|
|
|
Sarala Karumuri Subbarao
Sarala Subbarao obtained her Ph.D. from the University of Illinois in 1973. She specialized in Insect Genetics, Cytogenetics, Molecular Entomology and Epidemiology. She had a keen interest in malaria research and focused on the biology of malaria vectors and parasites and the epidemiology of malaria, which was also extended to other mosquito-borne diseases. Her research provided a new dimension to malaria epidemiology and control. She served on many Expert/Advisory committees of the WHO, ICMR institutes, DBT, DRDO. Dr. Subbarao was an elected Fellow of the Indian Society of Malaria and Other Communicable Diseases. She was recipient of the Dr. MOT Iyengar Memorial Award for Malaria Research; Best Scientist Award for research on Environmental Aspects of Vector-Borne Diseases by the NAVBD.
|
|
|
|
|
Do You Know?
In 2005, The National Cancer Institute launched The Cancer Genome Atlas Project, with an intial goal of mapping the genome of ovarian, brain and lung cancers.
|
|
|
Cancer News
|
New precision technology for immunotherapy
|
28 February 2022, EurekAlert
|
The method developed by the research team, ‘Tumour Surfaceome Mapping, TS-MAP’, makes it possible to carry out a direct analysis of all accessible cell surface tumour antigens in tumour tissue from patients...
|
|
|
|
|
|
|
|
|
|
|
� 2022 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
|
|